Logo for LaunchBio Program: Investor ConnectLogo for LaunchBio Program: Investor Connect

Bridging the gap between innovation and capital

Online

Luma Group

Focus on Biotech Therapeutic Companies

Program

Luma Group is an early-stage venture capital fund focused exclusively on life sciences. They invest in therapeutic, diagnostic, and medical device companies from Seed through Series B. They typically write initial checks from $5m – $20m and lead or co-lead financings but are also open to pre-seed and seed stages for promising companies.

Luma has a technology-first investment thesis and invests primarily in platform companies developing first-in-class or best-in-class assets. They partner with visionary founders to build transformative companies, not just by investing capital, but by sharing deep industry expertise, strategic guidance, and a strong network to help them grow and scale.

Event

LaunchBio, Browne Consulting, and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Luma Group.

To date, Luma Group has made six investments:

  • Five in therapeutics space spanning small molecules, CAR-T, peptides, recombinant proteins, and vaccines
  • One in diagnostics, focused on liquid biopsy screening

Applications will be selected based on meeting the following criteria:

Geography:
Open to investments globally

Company type:
Focus on therapeutics and diagnostic companies from Pre-Seed through Series B

Modalities of Interest:

  • Biologics
  • Protein-based therapies
  • Regenerative Medicine
  • RNA-based therapeutics
  • Small molecules
  • Vaccines


Therapeutic areas of interest include, but are not limited to:

  • Cardiology
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Hematology
  • Immunology
  • Metabolism
  • Neurology
  • Oncology
  • Ophthalmology
  • Pulmonology
  • Rare Diseases


Stage:
Companies seeking funding for Pre-Seed, Seed, Series A and Series B.

 


Qualifying start-ups can apply here today.

Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Browne Consulting and Silicon Valley Bank, a Division of First Citizens Bank.